Single-cell and spatial RNA sequencing identify perturbators of microglial functions with aging

Yifei Dong1, Rajiv W Jain1, Brian M Lozinski1

  • 1Hotchkiss Brain Institute and the Department of Clinical Neuroscience, University of Calgary, Calgary, Alberta, Canada.

Nature Aging
|April 28, 2023
PubMed

Insights

Aging impairs microglia, the brain's immune cells, leading to neurodegeneration. Osteopontin elevation in aging mice exacerbates damage, suggesting it as a target for restoring microglial function and treating neurological disorders.

Area of Science:

  • Neuroscience
  • Immunology
  • Aging Research

Background:

  • Microglia act as central nervous system immune sentinels, crucial for clearing neurotoxic substances like oxidized phosphatidylcholines (OxPCs).
  • Aging impairs microglial function, increasing susceptibility to neurological diseases such as multiple sclerosis and contributing to disability.

Purpose of the Study:

  • To investigate aging-driven changes in microglial function and gene expression.
  • To identify factors contributing to microglial dysfunction and neurodegeneration in aging.

Main Methods:

  • Single-cell and spatial RNA sequencing were employed on mouse spinal cords at young (6-week-old) and middle-aged (52-week-old) stages.
  • Oxidized phosphatidylcholine (OxPC) injury models were used to assess microglial responses in young and aged mice.
  • Osteopontin's role was evaluated through direct delivery and knockdown experiments.

Main Results:

  • Aging significantly altered microglial transcriptomes, with osteopontin notably elevated in middle-aged mice after OxPC injury.
  • Elevated osteopontin levels correlated with increased neurodegeneration.
  • Osteopontin exacerbated OxPC-induced lesions in young mice and contributed to microglial inflammation and axon loss in aged mice.

Conclusions:

  • Osteopontin is an aging-associated microglial transcript that impairs their protective functions.
  • Elevated osteopontin contributes to aging-associated neurodegeneration and multiple sclerosis pathology.
  • Targeting osteopontin may restore microglial homeostasis and mitigate neurodegenerative processes.

Related Concept Videos